203 related articles for article (PubMed ID: 2153076)
1. Induction of a variety of tumors by c-erbB2 and clonal nature of lymphomas even with the mutated gene (Val659----Glu659).
Suda Y; Aizawa S; Furuta Y; Yagi T; Ikawa Y; Saitoh K; Yamada Y; Toyoshima K; Yamamoto T
EMBO J; 1990 Jan; 9(1):181-90. PubMed ID: 2153076
[TBL] [Abstract][Full Text] [Related]
2. Driven by the same Ig enhancer and SV40 T promoter ras induced lung adenomatous tumors, myc induced pre-B cell lymphomas and SV40 large T gene a variety of tumors in transgenic mice.
Suda Y; Aizawa S; Hirai S; Inoue T; Furuta Y; Suzuki M; Hirohashi S; Ikawa Y
EMBO J; 1987 Dec; 6(13):4055-65. PubMed ID: 2832150
[TBL] [Abstract][Full Text] [Related]
3. A redundant nuclear protein binding site contributes to negative regulation of the mouse mammary tumor virus long terminal repeat.
Bramblett D; Hsu CL; Lozano M; Earnest K; Fabritius C; Dudley J
J Virol; 1995 Dec; 69(12):7868-76. PubMed ID: 7494299
[TBL] [Abstract][Full Text] [Related]
4. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
Krane IM; Leder P
Oncogene; 1996 Apr; 12(8):1781-8. PubMed ID: 8622899
[TBL] [Abstract][Full Text] [Related]
5. Mouse mammary tumor virus proviruses in T-cell lymphomas lack a negative regulatory element in the long terminal repeat.
Hsu CL; Fabritius C; Dudley J
J Virol; 1988 Dec; 62(12):4644-52. PubMed ID: 2846876
[TBL] [Abstract][Full Text] [Related]
6. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
[TBL] [Abstract][Full Text] [Related]
7. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.
Maroulakou IG; Oemler W; Naber SP; Tsichlis PN
Cancer Res; 2007 Jan; 67(1):167-77. PubMed ID: 17210696
[TBL] [Abstract][Full Text] [Related]
8. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice.
Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW
Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158
[TBL] [Abstract][Full Text] [Related]
9. Oncogenicity of the ret transforming gene in MMTV/ret transgenic mice.
Iwamoto T; Takahashi M; Ito M; Hamaguchi M; Isobe K; Misawa N; Asai J; Yoshida T; Nakashima I
Oncogene; 1990 Apr; 5(4):535-42. PubMed ID: 1691479
[TBL] [Abstract][Full Text] [Related]
10. An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice.
Stöcklin E; Botteri F; Groner B
J Cell Biol; 1993 Jul; 122(1):199-208. PubMed ID: 8100231
[TBL] [Abstract][Full Text] [Related]
11. Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands.
Jhappan C; Gallahan D; Stahle C; Chu E; Smith GH; Merlino G; Callahan R
Genes Dev; 1992 Mar; 6(3):345-55. PubMed ID: 1372276
[TBL] [Abstract][Full Text] [Related]
12. Mouse mammary tumor virus sequences responsible for activating cellular oncogenes.
Grimm SL; Nordeen SK
J Virol; 1998 Dec; 72(12):9428-35. PubMed ID: 9811675
[TBL] [Abstract][Full Text] [Related]
13. Preferential development of pre-B lymphomas with drastically down-regulated N-myc in the E mu-ret transgenic mice.
Iwamoto T; Pu M; Ito M; Takahashi M; Isobe K; Nagase F; Kawashima K; Ichihara M; Nakashima I
Eur J Immunol; 1991 Aug; 21(8):1809-14. PubMed ID: 1868872
[TBL] [Abstract][Full Text] [Related]
14. Extra mouse mammary tumor proviruses in DBA/2 mouse lymphomas acquire a selective advantage in lymphocytes by alteration in the U3 region of the long terminal repeat.
Yanagawa S; Murakami A; Tanaka H
J Virol; 1990 Jun; 64(6):2474-83. PubMed ID: 2159524
[TBL] [Abstract][Full Text] [Related]
15. Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice.
White DE; Cardiff RD; Dedhar S; Muller WJ
Oncogene; 2001 Oct; 20(48):7064-72. PubMed ID: 11704830
[TBL] [Abstract][Full Text] [Related]
16. Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors.
Romieu-Mourez R; Kim DW; Shin SM; Demicco EG; Landesman-Bollag E; Seldin DC; Cardiff RD; Sonenshein GE
Mol Cell Biol; 2003 Aug; 23(16):5738-54. PubMed ID: 12897145
[TBL] [Abstract][Full Text] [Related]
17. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
Zhou H; Chen WD; Qin X; Lee K; Liu L; Markowitz SD; Gerson SL
Oncogene; 2001 Sep; 20(42):6009-17. PubMed ID: 11593408
[TBL] [Abstract][Full Text] [Related]
18. The long terminal repeat region of the mouse mammary tumour virus contains multiple regulatory elements.
Mink S; Ponta H; Cato AC
Nucleic Acids Res; 1990 Apr; 18(8):2017-24. PubMed ID: 2159634
[TBL] [Abstract][Full Text] [Related]
19. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene.
Muller WJ; Sinn E; Pattengale PK; Wallace R; Leder P
Cell; 1988 Jul; 54(1):105-15. PubMed ID: 2898299
[TBL] [Abstract][Full Text] [Related]
20. Chemical effects in transgenic mice bearing oncogenes expressed in mammary tissue.
Tennant RW; Rao GN; Russfield A; Seilkop S; Braun AG
Carcinogenesis; 1993 Jan; 14(1):29-35. PubMed ID: 8093862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
